DOI: 10.1055/s-00050348

Indian Journal of Medical and Paediatric Oncology

References

Furuta H, Uemura T, Yoshida T. et al
Efficacy and safety data of osimertinib in elderly patients with NSCLC who harbor the EGFR T790M mutation after failure of initial EGFR-TKI treatment.

Anticancer Res 2018;
38 (09) 5231-5237

Download Bibliographical Data

Access:
Access: